Apellis Pharmaceuticals, Inc. (APLS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
10:04 am
Purchase
2021-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
Avoro Capital Advisors LLC8,555,555
8.900%
8,555,555increase
(New Position)
Filing
History
2022-02-09
3:24 pm
Purchase
2021-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
VANGUARD GROUP INC7,917,099
8.140%
2,375,274increase
(+42.86%)
Filing
History
2022-02-04
09:15 am
Purchase
2021-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
Wellington Management Group LLP12,478,253
12.830%
1,900,333increase
(+17.97%)
Filing
History
2022-02-03
4:41 pm
Sale
2021-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
BlackRock, Inc.
BLK
5,865,712
6.100%
-149,236decrease
(-2.48%)
Filing
History
Goto Prev, 0, 1, 2